What is the recommended dose of prednisone (corticosteroid) for treating a gout flare?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended dose of prednisone for treating a gout flare is 30-35 mg daily for 3-5 days, as suggested by high-quality evidence from the American College of Physicians guideline 1. This regimen is effective for most patients experiencing acute gout attacks. The medication should be taken with food to minimize gastrointestinal side effects. Prednisone works by reducing inflammation in the affected joint by suppressing the immune response that causes the painful symptoms of gout. The tapering schedule is important because abrupt discontinuation can lead to adrenal insufficiency or rebound inflammation. Patients with diabetes should monitor their blood glucose levels closely while taking prednisone, as it can cause elevations in blood sugar. Those with a history of peptic ulcer disease, hypertension, or psychiatric disorders should inform their healthcare provider, as prednisone may exacerbate these conditions. For recurrent gout attacks, preventive therapy with medications like allopurinol or febuxostat may be recommended rather than repeated courses of corticosteroids. Some key points to consider when treating gout flares with prednisone include:

  • Starting treatment as early as possible to minimize symptoms and prevent long-term damage
  • Monitoring for potential side effects, such as gastrointestinal issues, mood changes, and increased blood sugar levels
  • Adjusting the dose and duration of treatment based on individual patient needs and response to therapy
  • Considering alternative treatment options, such as colchicine or NSAIDs, for patients who cannot tolerate prednisone or have contraindications to its use.

From the Research

Recommended Dose of Prednisone for Gout Flare

The recommended dose of prednisone for treating a gout flare can vary depending on the study. Here are some key findings:

  • A study from 2018 2 suggests that prophylactic therapy with colchicine 0.5 mg PO QD or steroids 7.5 mg prednisone equivalent PO QD for 6 months can reduce the frequency and severity of acute gout flares during initiation of febuxostat for chronic gouty arthritis.
  • A 2008 study 3 found that oral prednisolone (35 mg once a day) was equivalent to naproxen (500 mg twice a day) in treating monoarticular gout, with similar reductions in pain scores.
  • A 1990 study 4 recommended a short course of oral corticosteroid therapy, such as prednisone 30 to 50 mg or its equivalent, initially and gradually tapered over 10 days, for acute gout when NSAIDs are contraindicated.
  • A 2024 study 5 is investigating the non-inferiority of prednisolone (30 mg for 5 days) compared to low-dose colchicine in patients with acute gout, with a primary outcome of pain reduction on day 3.
  • A 2014 systematic literature review 6 found that systemic glucocorticoids, including prednisone, were as effective as NSAIDs but safer in treating acute gout.

Key Points to Consider

  • The dose of prednisone for gout flare can range from 30 to 50 mg per day, depending on the study and patient population.
  • The duration of treatment can vary from 5 to 10 days, with some studies suggesting a gradual tapering of the dose.
  • Prednisone may be considered as an alternative to NSAIDs in patients with contraindications or intolerance to NSAIDs.
  • More research is needed to determine the optimal dose and duration of prednisone for gout flare treatment.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.